Disease-Modifying Therapy Use for Sickle Cell Remained Low 2014 to 2021

MONDAY, Nov. 27, 2023 -- From 2014 to 2021, uptake of disease-modifying treatments (DMTs) for sickle cell disease (SCD) remained low, according to a study published online Nov. 22 in JAMA Network Open. Terri Victoria Newman, Pharm.D., from the...
Source: Drugs.com - Pharma News - Category: Pharmaceuticals Source Type: news